Which peptides act through GLP-1 receptor agonism?
-
16Lr
Liraglutide
Earlier-generation GLP-1 receptor agonist studied in type 2 diabetes and weight management. UK prescription-only medicine; licence status depends on the brand.
Metabolic and incretinHuman trialsEvidence reviewedModerateLicensed UK medicine -
17Mz
Mazdutide
Not authorised in the UK; approved in China. Peptide that activates glucagon and GLP-1 receptors, studied in phase 3 trials in Chinese adults.
Metabolic and incretinHuman trialsEvidence reviewedStrongNot licensed in the UK -
24Sm
Semaglutide
GLP-1 receptor agonist studied in type 2 diabetes, weight management and cardiovascular outcomes. UK prescription-only medicine; studied in large randomised trials.
Metabolic and incretinHuman trialsEvidence reviewedStrongLicensed UK medicine -
28Sv
Survodutide
Investigational peptide that activates glucagon and GLP-1 receptors. Not authorised in the UK. Studied in phase 3 trials, all sponsor-funded.
Metabolic and incretinHuman trialsEvidence reviewedStrongNot licensed in the UK
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.